Non-Polio enterovirus infections cost-effectiveness of therapy

Non-Polio enterovirus infections Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Non-Polio enterovirus infections from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Non-Polio enterovirus infections cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Non-Polio enterovirus infections cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Non-Polio enterovirus infections cost-effectiveness of therapy
CDC on Non-Polio enterovirus infections cost-effectiveness of therapy
Non-Polio enterovirus infections cost-effectiveness of therapy in the news
Blogs on Non-Polio enterovirus infections cost-effectiveness of therapy
Directions to Hospitals Treating Non-Polio enterovirus infections
Risk calculators and risk factors for Non-Polio enterovirus infections cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Cost-Effectiveness of Therapy

The health care costs from enterovirus infections are unknown, but a large portion of the costs may come from use of over-the-counter medications to treat symptoms for millions of cases of "summer colds" and "flu" caused by enteroviruses. There are also significant costs associated with the 25,000 to 50,000 hospitalizations for aseptic meningitis each year in the United States.

References

Template:WikiDoc Sources